On the afternoon of the 16th, HLB Therapeutics' stock price surged during trading, triggering a Volatility Interruption (VI) mechanism and drawing keen attention from investors.

According to the Korea Exchange, a 'static VI' was triggered for HLB Therapeutics shares at 2:41 p.m. that day. At the time of activation, the price was 2,725 won, trading 10.10% higher than the static VI base price of 2,475 won. Approximately two minutes later, at 2:43 p.m., the VI was lifted and normal order-book trading resumed.

VI is a system that applies single-price trading for a certain period to stabilize the market and protect investors when an individual stock's price sharply rises or falls within a short period. In particular, a 'static VI' is activated when a price change exceeds a certain threshold compared to the most recent single price or the base price.

On this day, strong buying pressure flowed into HLB Therapeutics, widening price volatility. The market analyzes that a combination of recent improvement in investment sentiment across the overall biotech sector and individual stock issues are complexly influencing the stock price trend.

However, the VI trigger itself does not directly indicate a change in the company's fundamentals (value) or an improvement in earnings. As price volatility may temporarily expand due to short-term supply and demand changes, investors are required to take a particularly careful and cautious approach.

[※ This article was written with the assistance of an artificial intelligence (AI) analysis tool, and the final content was provided through an editorial process. The content included in this article is for informational purposes only and does not constitute a recommendation to buy or sell any specific stock or financial product. Investment decisions and the resulting responsibilities rest entirely with the investor. Actual results may vary depending on market conditions.]